Investors Asset Management of Georgia Inc. GA ADV Has $692,000 Stock Holdings in The Clorox Company (NYSE:CLX)

Investors Asset Management of Georgia Inc. GA ADV boosted its holdings in shares of The Clorox Company (NYSE:CLXFree Report) by 6.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,827 shares of the company’s stock after buying an additional 300 shares during the period. Investors Asset Management of Georgia Inc. GA ADV’s holdings in Clorox were worth $692,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Tyler Stone Wealth Management acquired a new position in Clorox during the second quarter worth $25,000. Strategic Investment Solutions Inc. IL acquired a new position in Clorox during the first quarter worth $31,000. Fortitude Family Office LLC acquired a new position in Clorox during the fourth quarter worth $29,000. First Capital Advisors Group LLC. purchased a new stake in shares of Clorox in the second quarter valued at about $35,000. Finally, Hartford Financial Management Inc. raised its holdings in shares of Clorox by 57.1% in the fourth quarter. Hartford Financial Management Inc. now owns 256 shares of the company’s stock valued at $37,000 after purchasing an additional 93 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Performance

CLX traded up $0.14 during trading on Thursday, hitting $142.48. 308,011 shares of the company traded hands, compared to its average volume of 1,197,686. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 11.37. The firm has a market cap of $17.68 billion, a P/E ratio of 225.86, a price-to-earnings-growth ratio of 2.22 and a beta of 0.43. The Clorox Company has a one year low of $114.68 and a one year high of $178.21. The stock’s fifty day moving average is $150.40 and its 200 day moving average is $141.69.

Clorox (NYSE:CLXGet Free Report) last issued its earnings results on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, topping analysts’ consensus estimates of $1.08 by $1.08. The firm had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.80 billion. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The company’s quarterly revenue was up 16.0% on a year-over-year basis. During the same quarter last year, the business earned $0.98 earnings per share. As a group, equities analysts predict that The Clorox Company will post 5.52 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be given a dividend of $1.20 per share. The ex-dividend date is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a yield of 3.37%. Clorox’s dividend payout ratio is presently 761.92%.

Analyst Ratings Changes

Several analysts have recently commented on CLX shares. UBS Group increased their target price on shares of Clorox from $145.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, February 2nd. The Goldman Sachs Group started coverage on shares of Clorox in a report on Friday, March 1st. They issued a “sell” rating and a $140.00 target price for the company. Morgan Stanley reiterated an “equal weight” rating and issued a $160.00 target price on shares of Clorox in a report on Tuesday, March 26th. DA Davidson reiterated a “neutral” rating and issued a $162.00 target price on shares of Clorox in a report on Wednesday. Finally, Citigroup lowered their target price on shares of Clorox from $165.00 to $155.00 and set a “neutral” rating for the company in a report on Tuesday. Four equities research analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $148.63.

Check Out Our Latest Stock Report on Clorox

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.